CMG
51
-3
EIX
56
2
URBN
74
4
VNO
52
-4
ROK
58
-2
PEG
55
5
NVDA
49
2
DHR
68
2
HCA
64
-2
D
45
4
WYNN
49
15
FIS
70
-2
NKE
48
5
LUV
70
2
RRC
63
-2
AIZ
63
4
AVGO
31
-7
COP
42
-5
NDAQ
70
-3
AAL
54
3
CMG
51
-3
EIX
56
2
URBN
74
4
VNO
52
-4
ROK
58
-2
PEG
55
5
NVDA
49
2
DHR
68
2
HCA
64
-2
D
45
4
WYNN
49
15
FIS
70
-2
NKE
48
5
LUV
70
2
RRC
63
-2
AIZ
63
4
AVGO
31
-7
COP
42
-5
NDAQ
70
-3
AAL
54
3
Financhill
Back

Columbia Research Enhanced Emerging Economies ETF Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Sell
50

ECON
Columbia Research Enhanced Emerging Economies ETF

Last Price:
$26.87
Seasonality Move:
0.33%
Sell
33

ZBIO
Zenas BioPharma, Inc.

Last Price:
$36.94
Seasonality Move:
-8.13%
Sell
50
Columbia Research Enhanced Emerging Economies ETF (ECON) is a Sell

Is Columbia Research Enhanced Emerging Economies ETF a Buy, Sell or Hold?

  • The current Columbia Research Enhanced Emerging Economies ETF [ECON] share price is $27.15. The Score for ECON is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • ECON is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Zenas BioPharma, Inc. (ZBIO) is a Sell

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $32.59. The Score for ZBIO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • ZBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ECON Stock Price Chart

What is Columbia Research Enhanced Emerging Economies ETF's stock price today?

  • The Columbia Research Enhanced Emerging Economies ETF share price today is $27.15
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ECON is experiencing selling pressure, which indicates risk of future bearish movement.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $32.59
    The current trend is moderately bullish and ZBIO is experiencing selling pressure, which indicates risk of future bearish movement.

ECON Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 48.03 Sell
Chaikin Money Flow: -4984 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.87 - 27.59) Sell
Bollinger Bands (100): (25.15 - 27.53) Buy

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.39 Buy
Relative Strength Index (14 RSI): 42.51 Sell
Chaikin Money Flow: -433025 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.8 - 39.38) Sell
Bollinger Bands (100): (16.79 - 33.43) Buy

ECON Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.31 Sell
20-day SMA: 27.1 Buy
50-day SMA: 27.33 Sell
200-day SMA: 24.45 Buy
8-day EMA: 27.25 Sell
20-day EMA: 27.24 Sell
50-day EMA: 27.05 Buy
200-day EMA: 25.02 Buy

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.44 Sell
20-day SMA: 37.66 Sell
50-day SMA: 32.27 Buy
200-day SMA: 17.45 Buy
8-day EMA: 37.61 Sell
20-day EMA: 34.32 Sell
50-day EMA: 23.15 Buy
200-day EMA: 7.97 Buy

Columbia Research Enhanced Emerging Economies ETF Earnings Growth & ECON Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

Columbia Research Enhanced Emerging Economies ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):